These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8678004)

  • 1. Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease.
    Taha AS; Curry GW; Morton R; Park RH; Beattie AD
    Am J Gastroenterol; 1996 Jul; 91(7):1407-9. PubMed ID: 8678004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori eradication treatment modulates epithelial cell proliferation and tissue content of hepatocyte growth factor in the gastric mucosa.
    Suzuki M; Suzuki H; Masaoka T; Tanaka S; Suzuki K; Ishii H
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():158-64. PubMed ID: 15298622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
    Gisbert JP; Boixeda D; Redondo C; Alvarez Baleriola I; Jiménez I; Pérez García JI; Pajares JM
    Rev Esp Enferm Dig; 1996 Apr; 88(4):259-64. PubMed ID: 9004796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Eradication of Helicobacter pylori in peptic ulcer and chronic gastritis. A randomized clinical trial].
    Rodríguez Hernández H; Sánchez Anguiano LF; Quiñones E
    Rev Gastroenterol Mex; 1998; 63(1):21-7. PubMed ID: 10068745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori normalizes elevated mucosal levels of epidermal growth factor and its receptor.
    Coyle WJ; Sedlack RE; Nemec R; Peterson R; Duntemann T; Murphy M; Lawson JM
    Am J Gastroenterol; 1999 Oct; 94(10):2885-9. PubMed ID: 10520838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
    Marzio L; Angelucci D; Grossi L; Diodoro MG; Di Campli E; Cellini L
    Am J Gastroenterol; 1998 Feb; 93(2):223-6. PubMed ID: 9468247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.
    Milutinovic AS; Todorovic V; Milosavljevic T; Micev M; Spuran M; Drndarevic N
    Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):755-66. PubMed ID: 12811306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the effects of Helicobacter pylori eradication therapy on gastric antral epithelial hyperproliferation: a prospective six-month follow-up study.
    Demiray M; Gulten M; Manavoglu O; Evrensel T; Ulukaya E; Yerci O; Kanat O; Kurt E; Arslan M; Gonullu G; Demiray H; Gulten T; Memik F
    Hepatogastroenterology; 2004; 51(59):1531-5. PubMed ID: 15362794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.
    Mak SK; Loo CK; Wong PN; Lo KY; Tong GM; Lam EK; Wong AK
    Singapore Med J; 2003 Feb; 44(2):74-8. PubMed ID: 14503780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
    Kubben FJ; Sier CF; Schram MT; Witte AM; Veenendaal RA; van Duijn W; Verheijen JH; Hanemaaijer R; Lamers CB; Verspaget HW
    Helicobacter; 2007 Oct; 12(5):498-504. PubMed ID: 17760717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
    Veldhuyzen van Zanten S; Hunt RH; Cockeram A; Schep G; Malatjalian D; Sidorov J; Matisko A; Jewell D
    Am J Gastroenterol; 1998 Jan; 93(1):5-10. PubMed ID: 9448164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation.
    Nakao K; Imoto I; Ikemura N; Shibata T; Takaji S; Taguchi Y; Misaki M; Yamauchi K; Yamazaki N
    Am J Gastroenterol; 1997 Jun; 92(6):1005-11. PubMed ID: 9177520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer].
    Gisbert JP; Mur M; Boixeda D; Ceña G; Martín de Argila C; Alvarez Baleriola I; Abraira V; García Plaza A
    Med Clin (Barc); 1997 Apr; 108(14):524-9. PubMed ID: 9190436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current therapy of Helicobacter pylori-induced chronic gastritis and/or peptic ulcer].
    Hentschel E
    Wien Klin Wochenschr; 1994; 106(17):543-6. PubMed ID: 7975668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Helicobacter pylori eradication on gastric histology, serum gastrin and pepsinogen I levels, and gastric emptying in patients with gastric ulcer.
    Maconi G; Lazzaroni M; Sangaletti O; Bargiggia S; Vago L; Bianchi Porro G
    Am J Gastroenterol; 1997 Oct; 92(10):1844-8. PubMed ID: 9382049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Helicobacter pylori on gastritis, pentagastrin-stimulated gastric acid secretion, and meal-stimulated plasma gastrin release in the absence of peptic ulcer disease.
    Hurlimann S; Dür S; Schwab P; Varga L; Mazzucchelli L; Brand R; Halter F
    Am J Gastroenterol; 1998 Aug; 93(8):1277-85. PubMed ID: 9707051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.